Nobiletin and its derivatives overcome multidrug resistance (MDR) in cancer: total synthesis and discovery of potent MDR reversal agents
Our recent studies demonstrated that the natural product nobiletin (NOB) served as a promising multidrug resistance (MDR) reversal agent and improved the effectiveness of cancer chemotherapy in vitro. However, low aqueous solubility and difficulty in total synthesis limited its application as a ther...
Saved in:
Main Authors: | Senling Feng (Author), Huifang Zhou (Author), Deyan Wu (Author), Dechong Zheng (Author), Biao Qu (Author), Ruiming Liu (Author), Chen Zhang (Author), Zhe Li (Author), Ying Xie (Author), Hai-Bin Luo (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of Myristicin in Association with Chemotherapies on the Reversal of the Multidrug Resistance (MDR) Mechanism in Cancer
by: Elisa Frederico Seneme, et al.
Published: (2022) -
Phytochemicals: Potential Lead Molecules for MDR Reversal
by: Boshra Tinoush, et al.
Published: (2020) -
Predictors of Multidrug-Resistant Tuberculosis (MDR-TB) in Sudan
by: Monadil H. Ali, et al.
Published: (2019) -
Disadvantage and the experience of treatment for multidrug-resistant tuberculosis (MDR-TB)
by: Holly A. Taylor, et al.
Published: (2022) -
Anlotinib Reverses Multidrug Resistance (MDR) in Osteosarcoma by Inhibiting P-Glycoprotein (PGP1) Function In Vitro and In Vivo
by: Gangyang Wang, et al.
Published: (2022)